Thyroid Clinical Trials in Houston, Texas
27 recruitingHouston, Texas
Showing 1–20 of 27 trials
Recruiting
Phase 1Phase 2
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Colorectal, CancerColorectal CarcinomaNon-small Cell Lung Cancer+29 more
Institut de Recherches Internationales Servier554 enrolled27 locationsNCT05786924
Recruiting
Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Malignant Neoplasm of Bone and Articular CartilageMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Independent (Primary) Multiple Sites+7 more
M.D. Anderson Cancer Center44 enrolled1 locationNCT03093909
Recruiting
Phase 1
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
MelanomaNon-small Cell Lung CancerThyroid Cancer+10 more
Pfizer124 enrolled82 locationsNCT05538130
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Head and Neck CarcinomaMalignant Solid NeoplasmSarcoma+59 more
Alliance for Clinical Trials in Oncology2,000 enrolled746 locationsNCT05334069
Recruiting
Phase 2
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Neoadjuvant TreatmentThyroid Cancer
M.D. Anderson Cancer Center45 enrolled2 locationsNCT06959511
Recruiting
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
Primary HyperparathyroidismParathyroid Gland CarcinomaParathyroid Gland Atypical Adenoma+1 more
M.D. Anderson Cancer Center310 enrolled1 locationNCT03039439
Recruiting
Phase 1
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
Thyroid Gland Carcinoma
M.D. Anderson Cancer Center42 enrolled1 locationNCT04589624
Recruiting
Phase 1Phase 2
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Breast CancerEsophageal CancerPancreatic Cancer+13 more
ModeX Therapeutics, An OPKO Health Company285 enrolled6 locationsNCT06239194
Recruiting
Phase 2
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
CancerPediatric CancerDifferentiated Thyroid Cancer+1 more
Children's Hospital of Philadelphia13 enrolled4 locationsNCT06458036
Recruiting
Not Applicable
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Metastatic Malignant Solid NeoplasmMetastatic MelanomaMetastatic Renal Cell Carcinoma+15 more
M.D. Anderson Cancer Center40 enrolled1 locationNCT04693377
Recruiting
Phase 1
Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
Thyroid Gland Anaplastic CarcinomaBRAF NP_004324.2:p.V600EBRAF V600K Mutation Present
City of Hope Medical Center6 enrolled3 locationsNCT03975231
Recruiting
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
Thyroid Cancer
M.D. Anderson Cancer Center459 enrolled1 locationNCT06507878
Recruiting
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Radiofrequency AblationPapillary Thyroid CancerLow Risk
M.D. Anderson Cancer Center50 enrolled1 locationNCT07140757
Recruiting
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Stage III Thyroid Gland Medullary Carcinoma AJCC v8Advanced Thyroid Gland Medullary CarcinomaStage IV Thyroid Gland Medullary Carcinoma AJCC v8+3 more
M.D. Anderson Cancer Center2,030 enrolled2 locationsNCT04216732
Recruiting
Phase 1
SLV-154 Treatment of Metastatic Solid Tumors
Breast Cancer MetastaticOvarian CancerEndometrial Cancer+7 more
Solve Therapeutics70 enrolled9 locationsNCT06771219
Recruiting
Not Applicable
Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
Thyroid Gland Medullary Carcinoma
M.D. Anderson Cancer Center120 enrolled1 locationNCT03892993
Recruiting
Phase 2
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
CancerPediatric CancerDifferentiated Thyroid Cancer+1 more
Children's Hospital of Philadelphia13 enrolled5 locationsNCT05783323
Recruiting
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Pediatric CancerPapillary Thyroid CancerDifferentiated Thyroid Cancer
Children's Hospital of Philadelphia32 enrolled9 locationsNCT05024929
Recruiting
The Myelin Disorders Biorepository Project
AdrenoleukodystrophyCockayne SyndromeRefsum Disease+63 more
Children's Hospital of Philadelphia12,000 enrolled23 locationsNCT03047369
Recruiting
Phase 2
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
Thyroid CancerThyroid CarcinomaPapillary Thyroid Cancer+3 more
Massachusetts General Hospital30 enrolled6 locationsNCT05668962